Issue 5/2019
Content (12 Articles)
Chemoradiotherapy for anal cancer: are we as good as we think?
D. Martin, C. Rödel, E. Fokas
Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer
Anastassia Löser, Burkhard Beyer, Cedric Oliver Carl, Benjamin Löser, Yamini Nagaraj, Thorsten Frenzel, Cordula Petersen, Andreas Krüll, Markus Graefen, Rudolf Schwarz
Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy
Ahmed Gawish, Ahmed Ali Chughtai, Michael J Eble
Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial
Elke Rammant, Piet Ost, Martijn Swimberghe, Barbara Vanderstraeten, Nicolaas Lumen, Karel Decaestecker, Renée Bultijnck, Gert De Meerleer, Camille Sarrazyn, Roos Colman, Valérie Fonteyne
Impact of androgen deprivation therapy on apparent diffusion coefficient and T2w MRI for histogram and texture analysis with respect to focal radiotherapy of prostate cancer
M. Daniel, P. Kuess, P. Andrzejewski, T. Nyholm, T. Helbich, S. Polanec, F. Dragschitz, G. Goldner, D. Georg, P. Baltzer
Institutional patient accrual volume and the treatment quality of I‑125 prostate seed implantation in a Japanese nationwide prospective cohort study
Katsumasa Nakamura, Saiji Ohga, Atsunori Yorozu, Shiro Saito, Takashi Kikuchi, Takushi Dokiya, Masanori Fukushima, Hidetoshi Yamanaka
Comparison of 68 Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer
Daniel Walacides, Astrid Meier, Anne Caroline Knöchelmann, Daniele Meinecke, Thorsten Derlin, Frank M. Bengel, Tobias L. Ross, Hans-Jürgen Wester, Katja Derlin, Markus A. Kuczyk, Christoph A. J. von Klot, Hans Christiansen, Christoph Henkenberens
The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy
Nina Poetsch, Alina Sturdza, Stefanie Aust, Stephan Polterauer, Christoph Grimm, Richard Schwameis, Richard Pötter, Heinz Koelbl, Alexander Reinthaller, Veronika Seebacher
A fatal case of Fournier’s gangrene during neoadjuvant radiotherapy for rectal cancer
Rainer Johannes Klement, Gabriele Schäfer, Reinhart A. Sweeney
Endokrine Funktionsstörungen nach Bestrahlung von Hirntumoren bei Kindern und jungen Erwachsenen
Sophia Scharl, Stephanie E. Combs
Einfluss der prophylaktischen Ganzhirnbestrahlung auf das Gesamtüberleben von Patienten mit einem fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom
Julia Schmidt, Steffen Appold, Esther G. C. Troost